Moderna Biopharma Canada Corporation
Registration:
10
of
16
(2023-10-19
to
2023-11-16)
Policies or Program
- Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
- Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
- The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
